Found: 5
Select item for more details and to access through your institution.
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 709, doi. 10.1002/ajh.23725
- By:
- Publication type:
- Article
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. E255, doi. 10.1002/ajh.23533
- By:
- Publication type:
- Article
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1762, doi. 10.1111/bjh.19419
- By:
- Publication type:
- Article
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 3, p. 456, doi. 10.1111/bjh.12635
- By:
- Publication type:
- Article
In-Practice Evaluation of OraVerse for the Reversal of Soft-Tissue Anesthesia After Dental Procedures.
- Published in:
- Compendium of Continuing Education in Dentistry (15488578), 2011, v. 32, n. 5, p. 58
- By:
- Publication type:
- Article